Type I Interferonopathy among Non-Elderly Female Patients with Post-Acute Sequelae of COVID-19
Viruses · 2024
DOI: 10.3390/v16091369 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Donghua Xu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Comparative Pathology, Tulane National Primate Research Center, Tulane University School of Medicine, Tulane University, 18703 Three Rive…. Hauptthemen laut MEDLINE: COVID-19, Interferon Type I, SARS-CoV-2, Monocytes. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, X.Q., American Heart Association.
Abstract (Originalsprache)
The pathophysiological mechanisms of the post-acute sequelae of COVID-19 (PASC) remain unclear. Sex differences not only exist in the disease severity of acute SARS-CoV-2 infection but also in the risk of suffering from PASC. Women have a higher risk of suffering from PASC and a longer time to resolution than men. To explore the possible immune mechanisms of PASC among non-elderly females, we mined single-cell transcriptome data from peripheral blood samples of non-elderly female patients with PASC and acute SARS-CoV-2 infection, together with age- and gender-matched non-PASC and healthy controls available from the Gene Expression Omnibus database. By comparing the differences, we found that a CD14+ monocyte subset characterized by higher expression of signal transducers and activators of transcription 2 (STAT2) (CD14+STAT2high) was notably increased in the PASC patients compared with the non-PASC individuals. The transcriptional factor (TF) activity analysis revealed that STAT2 and IRF9 were the key TFs determining the function of CD14+STAT2high monocytes. STAT2 and IRF9 are TFs exclusively involving type I and III interferon (IFN) signaling pathways, resulting in uncontrolled IFN-I signaling activation and type I interferonopathy. Furthermore, increased expression of common interferon-stimulated genes (ISGs) has also been identified in most monocyte subsets among the non-elderly female PASC patients, including IFI6, IFITM3, IFI44L, IFI44, EPSTI1, ISG15, and MX1. This study reveals a featured CD14+STAT2high monocyte associated with uncontrolled IFN-I signaling activation, which is indicative of a possible type I interferonopathy in the non-elderly female patients with PASC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Comparative Pathology, Tulane National Primate Research Center, Tulane University School of Medicine, Tulane University, 18703 Three Rivers Road, Covington, LA 70433, USA.
- Department of Microbiology and Immunology, School of Medicine, Tulane University, New Orleans, LA 70112, USA.
ORCID-Profile: Xuebin Qin
Förderung
- NIH HHS
- X.Q.
- American Heart Association
Zitieren
APA
Xu, D., & Qin, X. (2024). Type I Interferonopathy among Non-Elderly Female Patients with Post-Acute Sequelae of COVID-19. Viruses. https://doi.org/10.3390/v16091369
Vancouver
Xu D, Qin X. Type I Interferonopathy among Non-Elderly Female Patients with Post-Acute Sequelae of COVID-19. Viruses. 2024. doi:10.3390/v16091369
BibTeX
@article{Xu2024,
author = {Xu, Donghua and Qin, Xuebin},
title = {Type I Interferonopathy among Non-Elderly Female Patients with Post-Acute Sequelae of COVID-19},
journal = {Viruses},
year = {2024},
doi = {10.3390/v16091369}
}
EUVIMED